ANDREA NEWTON: Open Payments
NPI 1114636925 · ABINGDON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,397 in 151 payments from 23 companies in 2025. Trend: 2023 $2,108 · 2024 $3,300 · 2025 $3,397
Food & beverage: $3,397
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 23 | $881 |
| Novo Nordisk Inc | 23 | $531 |
| ABBVIE INC. | 22 | $436 |
| GlaxoSmithKline, LLC. | 15 | $304 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $199 |
| Amgen Inc. | 19 | $153 |
| Novartis Pharmaceuticals Corporation | 6 | $110 |
| Exact Sciences Corporation | 5 | $106 |
| Abbott Laboratories | 5 | $102 |
| Sumitomo Pharma America, Inc. | 4 | $86 |
Products named: TRELEGY ELLIPTA, Wegovy, QULIPTA, AIRSUPRA, LOKELMA, CAPLYTA, BREZTRI, FARXIGA.
Industry payments across VA — which companies pay providers there.
